NRG Oncology/Rtog 0415, Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer: Prostate-Specific Quality of Life Results

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2016.06.023
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Long-Term Follow-Up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non–small Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Initial Report of NRG Oncology/Rtog 0232: A Phase 3 Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy With Brachytherapy Alone for Selected Patients With Intermediate-Risk Prostatic Carcinoma

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Knowledge Engineering-Based Quality Evaluation of NRG Oncology RTOG 0522 Treatment Plans

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Toxicity and Quality of Life Report of a Phase 2 Study of Stereotactic Body Radiation Therapy (SBRT) for Low- And Intermediate-Risk Prostate Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Updated 4-Year Results for NRG Oncology/Rtog 0921: A Phase 2 Study of Postoperative Intensity Modulated Radiation Therapy With Concurrent Cisplatin and Bevacizumab Followed by Carboplatin and Paclitaxel for Patients With Endometrial Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Successful Phase 2 Trial of Ultrafocal Brachytherapy for Low/Intermediate Risk Prostate Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Mp86-14 Prostate Specific Antigen and Health-Related Quality-Of-Life Outcomes in Uninsured Men With Prostate Cancer

Journal of Urology
Urology
2017English

Quality of Life of Patients With Prostate Cancer. Prospective Study Using the CAVIPRES Questionnaire

Anales del Sistema Sanitario de Navarra
Medicine
2016English

Significant Association of Brachytherapy Boost With Reduced Prostate Cancer–specific Mortality in Contemporary Patients With Localized, Unfavorable-Risk Prostate Cancer

Brachytherapy
Nuclear MedicineRadiologyImagingOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy